Massiré Traoré

ORCID: 0000-0003-3767-2620
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Muscle Physiology and Disorders
  • Ion channel regulation and function
  • Adipose Tissue and Metabolism
  • Photoreceptor and optogenetics research
  • Glycogen Storage Diseases and Myoclonus
  • Metabolism, Diabetes, and Cancer
  • Transcranial Magnetic Stimulation Studies
  • Pancreatic function and diabetes
  • Neurogenetic and Muscular Disorders Research
  • RNA Research and Splicing
  • Nuclear Structure and Function
  • Genetic factors in colorectal cancer
  • Extraction and Separation Processes
  • Erythrocyte Function and Pathophysiology
  • Digestive system and related health
  • Muscle metabolism and nutrition
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Cardiomyopathy and Myosin Studies
  • Stroke Rehabilitation and Recovery
  • Cardiac electrophysiology and arrhythmias
  • Minerals Flotation and Separation Techniques
  • Electromagnetic Fields and Biological Effects
  • Cancer-related gene regulation
  • Epigenetics and DNA Methylation
  • Bauxite Residue and Utilization

Inserm
2015-2024

Sorbonne Université
2019-2024

Centre de Recherche en Myologie
2017-2024

Pitié-Salpêtrière Hospital
2024

Institut de Myologie
2023-2024

Université Paris Cité
2015-2021

Centre National de la Recherche Scientifique
2015-2021

Institut Cochin
2015-2021

Inova Design Solutions (United Kingdom)
2018

Physiologie de la Reproduction et des Comportements
2018

Abstract Excessive glucose production by the liver is a key factor in hyperglycemia observed type 2 diabetes mellitus (T2DM). Here, we highlight novel role of kinase B1 (Lkb1) this regulation. We show that mice with hepatocyte-specific deletion Lkb1 have higher levels hepatic amino acid catabolism, driving gluconeogenesis. This effect during both fasting and postprandial period, identifying as critical suppressor Hepatic associated major changes whole-body metabolism, leading to lower lean...

10.1038/s41467-020-19490-6 article EN cc-by Nature Communications 2020-11-30

CaVβ1E boosts downstream growth differentiation factor 5 signaling to counteract muscle mass loss in denervated or aged mouse muscles.

10.1126/scitranslmed.aaw1131 article EN Science Translational Medicine 2019-11-06

Hepatocellular carcinomas (HCCs) are known to be highly heterogenous. Within the extensive histopathological and molecular heterogeneity of HCC, tumors with mutations in CTNNB1, encoding β-catenin (CTNNB1-mutated HCC), constitute a very homogeneous group. We previously characterized distinctive metabolic histological phenotype for CTNNB1-mutated HCC. They were found well-differentiated, almost never steatotic, often cholestatic, microtrabecular or acinar growth pattern. Here, we investigated...

10.1002/path.5202 article EN The Journal of Pathology 2018-12-19

Background LKB1 is an evolutionary conserved kinase implicated in a wide range of cellular functions including inhibition cell proliferation, regulation polarity and metabolism. When Lkb1 inactivated the liver, glucose homeostasis perturbed, affected cholestasis develops. Cholestasis occurs as result from deficient bile duct development, yet how impacts on biliary morphogenesis unknown. Methodology/Principal Findings We characterized phenotype mice which deletion gene has been specifically...

10.1371/journal.pone.0145400 article EN cc-by PLoS ONE 2015-12-21

Abstract Sarcopenia involves a progressive loss of skeletal muscle force, quality and mass during ageing, which results in increased inability death; however, no cure has been established thus far. Growth differentiation factor 5 (GDF5) described to modulate maintenance various contexts. For our proof concept, we overexpressed GDF5 by AAV vector injection tibialis anterior adult aged (20 months) mice performed molecular functional analysis muscle. We analysed human vastus lateralis biopsies...

10.1093/brain/awae107 article EN Brain 2024-04-08

Sarcopenia is a complex age-related muscular disease affecting 10 to 16 % of people over 65 years old. It characterized by excessive loss muscle mass and strength. Despite plethora studies aimed at understanding the physiological mechanisms underlying this pathology, pathophysiology sarcopenia remains poorly understood. To date, there no pharmacological treatment for disease. In context, our team develop therapeutic approaches based on GDF5 protein counteract function in various pathological...

10.1051/medsci/2023143 article FR médecine/sciences 2023-11-01

Abstract Magnetic brain stimulation is a promising treatment in neurology and psychiatry, but clinical outcomes are variable. Unfortunately, mechanisms underlying magnetic effects ill-defined, which impedes the development of protocols appropriate for different neurological conditions. Here we show, vivo ex , that repetitive transcranial at low-intensity (LI-rTMS) induces axon outgrowth synaptogenesis to repair neural circuit. This depends on pattern, with complex patterns being particularly...

10.1101/424317 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2018-09-23
Coming Soon ...